Resapp Health Ltd
ASX:RAP
Resapp Health Ltd
ASX:RAP
Price:
0.205 AUD
Market Closed
Updated:
Apr 27, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of RAP.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RAP
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
RAP Competitors Multiples
Resapp Health Ltd Competitors
Resapp Health Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Resapp Health Ltd
ASX:RAP
|
176.2m AUD | 70.1 | -24.8 | -25 | -25 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 13.7 | 61.6 | 61.4 | 66.1 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1.3T JPY | 5.4 | 27.5 | 14.6 | 16.4 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 78.1 | 163.9 | 112.7 | 112.7 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | 11.2 | -331.8 | -175.3 | -162.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 9.5 | 32.2 | 21.5 | 22.9 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.7B SEK | 26.1 | 100.6 | -66.2 | -66.2 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -22.1 | 26.1 | 277.7 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.8 | -319.5 | 34.1 | -111.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
